Comorbidities and polypharmacy among HIV-positive patients aged 50 years and over: a case–control study

Autor: Moisés Hermilo Martínez-Osio, Alberto Chaparro-Sánchez, Luis Antonio Uribe-Noguez, Carla Ileana Arroyo-Anduiza, Jesús Gaytán-Martínez, Itzel Cruz-Grajales, Medardo Jerónimo-Morales, José Antonio Mata-Marín, Javier Enrique Cruz-Herrera, María de los Ángeles Berrospe-Silva
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: BMC Research Notes, Vol 12, Iss 1, Pp 1-6 (2019)
BMC Research Notes
ISSN: 1756-0500
DOI: 10.1186/s13104-019-4576-6
Popis: Objective This study was to determine and compare the prevalences of polypharmacy and comorbidities in patients aged 50 years or older with those patients younger than 50 years in a Mexican population. Results One hundred and twenty-five patients were enrolled, 60 (48%) were aged 50 years or older. The median CD4+ cell counts were 509 cells/μL (interquartile range [IQR]: 324–730) for the older patients and 384 cells/μL (IQR: 262–562) (P = 0.021) for the younger patients. Viral suppression were significantly higher in the older group: 80% vs. 63% (P = 0.037). The number of comorbidities was significantly higher in the older group, with a median of 2 (IQR: 2–3) vs. 1 (IQR: 0–1) (P ≤ 0.001). After adjustment of the logistic regression model in the older group, the following comorbidities differed between the age groups: systemic arterial hypertension (odds ratio [OR]: 15.75; 95% confidence interval [CI] 3.49–71.05; P =
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje